VIDEO: Linaclotide yields early reduction in IBS with constipation symptoms
Click Here to Manage Email Alerts
LAS VEGAS – Darren M. Brenner, MD, reported at the ACG Annual Scientific Meeting that linaclotide reduces abdominal pain and other symptoms of irritable bowel syndrome with constipation within 4 weeks of treatment.
“Importantly, if you allow the patient to continue to take the medication for more than 4 weeks, you may see improvements in 10% to 15% of individuals after that with respect to their abdominal or bowel symptoms,” Brenner said.
Collapse
Brenner DM, et al. Time to relief of key abdominal and bowel symptoms of irritable bowel syndrome with constipation: A post-hoc analysis of randomized controlled trials of linaclotide. Presented at: ACG Scientific Annual Meeting; Oct. 22-27, 2021; Las Vegas (hybrid meeting).
Read more about
Click Here to Manage Email Alerts